New Acuitas Therapeutics Video
Acuitas Therapeutics partners with pharmaceutical companies, biotechnology companies and academic institutes to advance nucleic acid therapeutics to the clinic and to the marketplace. After more than a decade of work on our lipid nanoparticle delivery system, it now plays a
What You Need to Know About COVID-19 Vaccines for Children
The Pfizer/BioNTech COVID-19 vaccine COMIRNATY® has received Health Canada’s approval for children ages five to 11. (Acuitas provides the lipid nanoparticle delivery system for this mRNA vaccine.) In a CBC article, which is in a useful Q&A format, a spokesperson for
A Surreal (and Incredible) Moment in Time
M.D. is a Preclinical Scientist at Acuitas Therapeutics. In early March 2020, President & CEO Dr. Thomas Madden reached out to the Acuitas team and told them that they needed to go home because a global pandemic had just been